iiinova — where your digital self keeps evolving

FirstWord Group @firstwordgroup.com · 20h

Tumour RNA in urine could help detect bladder cancer, guide treatment firstwordhealthtech.com/story/8155203

firstwordhealthtech.com

000

FirstWord Group @firstwordgroup.com · 20h

Withings adds AI heart murmur, breathing analysis to BeamO firstwordhealthtech.com/story/8155782

firstwordhealthtech.com

000

FirstWord Group @firstwordgroup.com · 21h

Bayer plans $2.2B manufacturing campus in Ohio $BAYN firstwordpharma.com/story/8155890

000

FirstWord Group @firstwordgroup.com · 21h

EU revokes Hansoh's Aumseqa nod after AstraZeneca challenge $AZN firstwordpharma.com/story/8154550

000

FirstWord Group @firstwordgroup.com · 02/10/2026

Amprion, Prema Cognition link up on multimodal neurodegenerative disease testing firstwordhealthtech.com/story/8150974

firstwordhealthtech.com

000

FirstWord Group @firstwordgroup.com · 02/10/2026

Talus Bio looks beyond protein structures with new AI drug discovery model firstwordhealthtech.com/story/8151764

firstwordhealthtech.com

000

FirstWord Group @firstwordgroup.com · 30/09/2026

Duke looks to digital twins to track patients' health over time firstwordhealthtech.com/story/8125826

firstwordhealthtech.com

001

FirstWord Group @firstwordgroup.com · 29/09/2026

PhRMA names former Majority Leader Eric Cantor as new CEO firstwordpharma.com/story/8124011

000

FirstWord Group @firstwordgroup.com · 29/09/2026

Newco ai3Bio bags $48M to take aim at disease-driving Th17 cells firstwordpharma.com/story/8125823

000

FirstWord Group @firstwordgroup.com · 29/09/2026

Former Genentech scientists launch 'AI lab' newco with $500M $RHHBY firstwordpharma.com/story/8120275

000

FirstWord Group @firstwordgroup.com · 29/09/2026

Oura hits pause on IPO plans due to market 'uncertainty' #wearables firstwordhealthtech.com/story/8120087

firstwordhealthtech.com

000

FirstWord Group @firstwordgroup.com · 29/09/2026

FDA approves first treatment in US for rare thyroid hormone disorder $EGTX firstwordpharma.com/story/8119146

000

FirstWord Group @firstwordgroup.com · 29/09/2026

Roche charts path from AI-assisted research to lab autonomy $RHHBY firstwordpharma.com/story/8114093

000

FirstWord Group @firstwordgroup.com · 29/09/2026

More than half of lupus patients taking Adicet's CAR-T went into remission $ACET firstwordpharma.com/story/8114019

000

FirstWord Group @firstwordgroup.com · 29/09/2026

Mirum tees up filing for hepatitis delta hopeful after Phase III win $MIRM $VIR $GILD firstwordpharma.com/story/8113851

000

FirstWord Group @firstwordgroup.com · 29/09/2026

BARDA awards Scynexis up to $214M to advance antifungal $SCYX firstwordpharma.com/story/8113664

000

FirstWord Group @firstwordgroup.com · 29/09/2026

Tolerance furthers thymus-targeting strategy in $560M Tanabe deal firstwordpharma.com/story/8113130

000

FirstWord Group @firstwordgroup.com · 29/09/2026

Kodiak surges on Phase III victory for Eylea rival in wet AMD $KOD $BAYN $REGN firstwordpharma.com/story/8111815

000

FirstWord Group @firstwordgroup.com · 29/09/2026

AstraZeneca antes up $2B for 10% stake in Summit $AZN $SMMT firstwordpharma.com/story/8114125

000

FirstWord Group @firstwordgroup.com · 26/09/2026

Merck & Co., Daiichi withdraw US submission for ADC in lung cancer $MRK $DSNKY firstwordpharma.com/story/8102182

000

FirstWord Group @firstwordgroup.com · 26/09/2026

Five-year data demonstrate 'curative potential' of Carvykti in MM $JNJ $LEGN firstwordpharma.com/story/8099744

000

FirstWord Group @firstwordgroup.com · 26/09/2026

Rare bone disorder gets a third FDA-cleared treatment with Mirum's Atebrioz $MIRM $REGN $IPSEY firstwordpharma.com/story/8101947

000

FirstWord Group @firstwordgroup.com · 26/09/2026

US approves Roche's Gazyva to prevent nephrotic syndrome relapses $RHHBY firstwordpharma.com/story/8101685

000

FirstWord Group @firstwordgroup.com · 26/09/2026

Minoryx, Neuraxpharm win EU nod for cALD therapy firstwordpharma.com/story/8100783

000

FirstWord Group @firstwordgroup.com · 26/09/2026

ADARx bags $446.3M IPO as another siRNA startup readies for its debut firstwordpharma.com/story/8101905

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Lilly ordered to pay Nektar $90M in damages over rezpeg dispute $LLY $NKTR firstwordpharma.com/story/8099224

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Overton affirms vaccine safety in Senate hearing, but hedges on mifepristone firstwordpharma.com/story/8097483

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Precision Neuroscience scores $250M to move less-invasive BCI to market firstwordhealthtech.com/story/8097020

firstwordhealthtech.com

000

FirstWord Group @firstwordgroup.com · 25/09/2026

FDA clears Welireg, Lenvima for post-immunotherapy kidney cancer $MRK $ESALF firstwordpharma.com/story/8097145

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Acadia touts 'Phase III-enabling' data despite miss in Alzheimer's psychosis $ACAD firstwordpharma.com/story/8096735

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Kasvu snags €30M for its neuroplastogen approach to depression firstwordpharma.com/story/8096638

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Roche taps Earendil's AI tech for bispecific discovery in $1.5B deal $RHHBY firstwordpharma.com/story/8095979

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Merck & Co.'s Wnt drug wins in ophthalmology study, but safety concerns crop up $MRK firstwordpharma.com/story/8095954

000

FirstWord Group @firstwordgroup.com · 25/09/2026

Kyverna says its CAR-T holds up in neurologic autoimmune diseases $KYTX firstwordpharma.com/story/8095250

000

FirstWord Group @firstwordgroup.com · 24/09/2026

Australia investigates after OpenAI agent breaches healthcare database firstwordhealthtech.com/story/8096460

firstwordhealthtech.com

001

FirstWord Group @firstwordgroup.com · 24/09/2026

Elevar gets US nod for FGFR2-targeted cholangiocarcinoma drug firstwordpharma.com/story/8082548

000

FirstWord Group @firstwordgroup.com · 24/09/2026

FDA panel backs efficacy of Grail's cancer test in tight vote firstwordpharma.com/story/8092506

000

FirstWord Group @firstwordgroup.com · 24/09/2026

Enveda bags $311M to advance trio of AI-discovered assets firstwordpharma.com/story/8082556

000

FirstWord Group @firstwordgroup.com · 24/09/2026

Anthropic's AI finds an overlooked enzyme system hiding in phage DNA firstwordpharma.com/story/8082779

000

FirstWord Group @firstwordgroup.com · 24/09/2026

Flagship wins $47M Department of War award for AI-informed countermeasures firstwordpharma.com/story/8082770

000

FirstWord Group @firstwordgroup.com · 24/09/2026

ArcaScience brings an AI lens to drug benefit-risk tradeoffs firstwordpharma.com/story/8082468

000

FirstWord Group @firstwordgroup.com · 24/09/2026

Basecamp raises $140M to turn 'Trillion Gene' trove into therapies firstwordpharma.com/story/8082010

000

FirstWord Group @firstwordgroup.com · 23/09/2026

Vertex makes case for broader use of kidney disease candidate $VRTX firstwordpharma.com/story/8079362

000

FirstWord Group @firstwordgroup.com · 23/09/2026

Circular Genomics, Altoida link AI with blood biomarkers to track Alzheimer's #dementia firstwordhealthtech.com/story/8078947

firstwordhealthtech.com

000

FirstWord Group @firstwordgroup.com · 22/09/2026

Amgen's Horizon-sourced fusion protein succeeds in late-stage Sjögren's study $AMGN firstwordpharma.com/story/8078935

000

FirstWord Group @firstwordgroup.com · 22/09/2026

Pharma giants set out to predict drug binding with AI $ABBV $AZN $BMY $JNJ firstwordpharma.com/story/8078550

000

FirstWord Group @firstwordgroup.com · 22/09/2026

Iambic hopes to springboard from pharma collabs onto NASDAQ firstwordpharma.com/story/8078519

000

FirstWord Group @firstwordgroup.com · 22/09/2026

Otsuka claims Phase III win for ulefnersen in rare genetic ALS $IONS firstwordpharma.com/story/8077511

000

FirstWord Group @firstwordgroup.com · 22/09/2026

European pharma's 'slow agony' of decline draws warning from nine industry chairs $AZN $GSK $IPN $NVO $NVS $RHHBY $SNY firstwordpharma.com/story/8078233

000

FirstWord Group @firstwordgroup.com · 22/09/2026

Boehringer taps Envisagenics' AI to mine RNA splicing for cancer targets firstwordpharma.com/story/8077452

000